About JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND
Expense ratio
0.40%
Home page
Inception date
May 9, 2022
ISIN
CNE100005B86
Closely tracks the underlying index, and pursues the minimization of tracking deviation and tracking err.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region